Work

Abstract 1718: RT023, a first-in-class CEACAM5/EGFR targeted bispecific antibody drug conjugate (ADC) in colorectal cancer (CRC)

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-1718

Authors: Shuting Huang, Lulu Zhou, Jingjing Cao, Lingli Bi, Qiang Fu, Xuan Wu, Aikun Xia, Jiaming Wang, Yue Deng, Yanghua Xu, Xin Wang, Wenli Shi, Honglin He, Yuyuan Yan, Ziyang Zhong

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148872411

Cites:

Cited by: 1

Related to: